Who Pays for Tests, Travel, and Complications When You Join a Clinical Trial in China?

After receiving information about a study recruiting participants, first ask the research team at the specific hospital for the informed consent form and a breakdown of costs. List expenses for screening, treatment, follow-up, and after returning home. Confirm who pays, whether you must pay upfront, and who provided the answers. Before booking tickets, also ask the doctor to confirm the expected visits and travel arrangements.

Key points

  • Article 8 of China’s Regulations for the Implementation of the Drug Administration Law states that drug clinical trial sponsors and institutions must not charge participants fees related to the trial. The drug Good Clinical Practice (GCP) rules revised in 2026 also require sponsors to provide trial drugs free of charge and pay for related medical tests.
  • A single test order may cover research needs, routine care, or both. Ask the research team to explain how each item is classified and why. If you question a charge, the consent form or a verbal answer alone cannot establish whether it complies with the rules.
  • Travel reimbursement, payments for participating in research, and treatment and compensation for trial-related harm are separate matters. Relevant ethics rules cover compensation for reasonable expenses; the specific items, scope, and procedures need to be checked.
  • In a medical emergency, seek care nearby first and contact the research team as soon as possible. Rules assign responsibility for treatment costs and compensation for trial-related harm. Ask in advance whom to contact and how upfront payments are handled.

First, confirm what type of study you are joining

Ask the research coordinator to provide the study name, registration number, hospital and campus, study type, and person in charge in writing, along with an informed consent form you can understand. Registration information or a preliminary match does not mean you have been enrolled; the research team still needs to assess your eligibility.

For drug clinical trials in China, Article 8 of the Regulations for the Implementation of the Drug Administration Law, effective May 15, 2026, states that sponsors and trial institutions must not charge participants fees related to the trial. Article 45 of the drug GCP rules, effective September 1, 2026, further requires sponsors to provide clinical trial drugs free of charge and pay for trial-related medical tests. Implementing Regulations · Drug GCP

Other types of research have their own protections. Saying “the consent form governs” cannot replace legal requirements. For example, medical device clinical trials must not charge participants trial-related fees in any form. The applicable Measures for the Ethical Review of Life Science and Medical Research Involving Humans prohibit research-related charges and require appropriate compensation for reasonable expenses incurred through participation. Investigator-initiated observational studies must not impose additional financial burdens beyond what is needed for routine care or disease prevention and control. Interventional studies also have requirements for costs and compensation for reasonable expenses. The research team should explain which rules apply to the study. Medical Device Regulations · Article 17 of the Ethical Review Measures · Measures for Managing Investigator-Initiated Clinical Research

Clarify every cost before deciding whether to travel

Ask the research coordinator and the hospital billing department to check the costs together. For each item, record its purpose, when it occurs, who pays, whether you must pay upfront, the required receipts, and when payment is made. If you are asked to pay a cost, ask why it is not considered research-related.

Item What to confirm
Screening and tests What is the purpose of each records prescreening, outpatient visit, pathology review, genetic test, imaging test, biopsy, and repeat screening? How are costs settled if you do not pass screening?
Study treatment How are trial drugs, drug administration procedures, premedication, hospitalization, and protocol-required tests classified and paid for? Do not accept labels such as “hospitalization” or “routine test” alone as a basis for charging you.
Other medical care Are there charges for pre-existing conditions, coexisting conditions, regular medicines, and care independent of the study? Is an itemized estimate available? Request a review if there is a dispute over any research-related portion.
Travel and accompanying support Is support available for visas, interpreting, transport, accommodation, meals, an accompanying person, and booking changes? Which count as reasonable expenses incurred through participation, and how do you apply for compensation?
At the end and after returning home Who arranges and pays for final tests, safety follow-up, care for ongoing symptoms, local tests, and subsequent routine treatment?

Ask the study site for a dated written response specific to your cohort, along with a contact person. List estimated costs separately from items that remain uncertain; a study registration page or promotional page cannot replace the hospital’s itemized information. Ask your public health insurance administrator or private insurer whether the services, locations, pre-existing conditions, and clinical research are covered, whether prior authorization or upfront payment is required, and which receipts you must keep. Also ask the hospital which payment methods it accepts.

If a hospital or intermediary requests payment for costs that appear to be research-related, ask for an itemized breakdown, the basis for the charges, and a written explanation. Contact the principal investigator, the hospital’s clinical trial office, or its ethics committee for a review. If the dispute remains unresolved, you can consult the local drug regulator or health authority. Do not pay into a personal account without obtaining official proof of payment. While costs remain disputed, ask the team to explain arrangements that will avoid delaying necessary treatment.

How are screening and travel costs handled?

Ask the study site for a schedule of screening, drug administration, tests, the final visit, and follow-up. It should show the time window for each visit, whether you must attend the site in China, and whether it can be completed where you live. Budget for the number of round trips, accommodation, an accompanying person, and possible delays. Ask the study doctor to assess when it is appropriate for you to leave or fly.

Applicable ethics rules require appropriate compensation for reasonable expenses incurred through research participation. The institution must clarify which expenses qualify, whose expenses are covered, the amounts, and the required receipts, based on the applicable rules and the study’s circumstances. Do not assume that airfare, all accommodation, or an accompanying person’s expenses will be reimbursed in full. Equally, a lack of study funding alone does not establish that compensation is not required. Ask what happens if you fail screening, withdraw, change bookings, or need to return to the hospital. List reimbursements separately from payments for your time and inconvenience.

You can send this to the coordinator:

I am considering joining [study number, hospital, and campus]. Please provide the visit schedule and an itemized explanation of costs. How are costs settled if I fail screening or need repeat screening? Which travel and accommodation costs qualify as reasonable expenses eligible for compensation? Does this include an accompanying person, booking changes, and the return journey after withdrawal? What receipts are required, must I pay upfront, who reviews the claim, and how long does payment take? If I must pay for an item, please explain the basis for this.

If complications occur, who is responsible for treatment and payment?

If symptoms are severe or worsen quickly, seek emergency care nearby first. Do not wait for a decision about costs. Notify the research team as soon as possible. Show the emergency doctor your trial contact card, medication information, and the site’s emergency phone number. Keep medical records, itemized bills, and receipts, and ask the doctors on both sides to exchange necessary information.

For studies covered by the Measures for the Ethical Review of Life Science and Medical Research Involving Humans, research-related harm should receive prompt treatment free of charge, with compensation or damages provided under applicable laws and agreements. The institution and relevant professionals should verify the specific rules and responsibilities that apply. Ethical Review Measures

For drug clinical trials, Article 45 of GCP requires the sponsor to cover diagnosis and treatment costs and provide corresponding compensation or damages for harm related to trial participation. Its insurance or guarantee arrangements have an explicit exception for harm caused by the investigators’ or institution’s own negligence. Not every symptom occurring during a trial has been established as trial-related. Ask in advance which hospital you can use for emergency care, who pays upfront, how matters are handled during a dispute, who assesses whether the harm is trial-related, how to request a review, and how emergency care outside China, medical transport, and extra accommodation are handled. Waiting for a determination must not be used as a reason to delay emergency care. Drug GCP

How are costs and care managed after stopping the trial drug or returning home?

Stopping the trial drug, completing your individual follow-up, and the end of the entire study may occur on different dates. Ask the research team to explain each final test, adverse event requiring continued monitoring, visit, and cost; which can be handled where you live; who reviews the results; and who contacts you. Depending on the specific intervention, ask how long extended follow-up may last, which tests and activity restrictions are needed, who receives the results, and who pays. Ask your doctor where you live to confirm that they can take over your care, and arrange your next appointment. If continued access to the study drug is uncertain, also ask the doctors on both sides to discuss a transition plan.

Before leaving, keep the trial number, research team and emergency contact details, details of the intervention and the date it was last given or used, adverse events and their management, current medicines, test reports, the next visit window, and a list of pending results. Send the records to the receiving doctor through a secure channel approved by the hospital; store invoices and receipts separately. If you need continued medication or a referral, ask the research team to explain the drug supply, receiving provider, and transition arrangements in writing.

Frequently asked questions

If I fail screening, can I still be charged for study tests?

First ask the study site to explain, item by item, whether each cost is trial-related, who settles it, and on what basis. Failing screening should not be treated as an automatic reason to charge you. Check travel compensation and non-research medical costs separately. If you have concerns about whether the response meets applicable rules, contact the clinical trial office or ethics committee.

Does the sponsor always pay all protocol-related costs directly?

Rules prohibit charging participants for drug trial-related costs, and the sponsor must pay for related medical tests. Ask the site to explain the specific billing arrangements, whether any upfront payment may arise, and how it is handled, and check whether these arrangements comply with applicable rules. A study’s payment arrangements cannot replace legal obligations.

What should I do if a recruitment platform asks for a deposit upfront?

Pause payment. Contact the hospital’s clinical trial office through its publicly listed channels to verify the study, who is charging, the purpose of the charge, and its basis. Request an official itemized statement and proof of payment. Request a review of any suspected research-related charges.

If my insurer agrees to cover the costs, do I still need to ask the study site?

Yes. Ask the insurer to explain in writing the coverage for specific services, limits, prior authorization requirements, and exclusions, then compare these item by item with the site’s cost list. Do not assume that possible insurance payment removes the research parties’ applicable obligations.

What if I have side effects but it is not yet clear whether they are trial-related?

Seek timely medical care based on your condition and contact the research team. Ask the team to record your symptoms and treatment and explain the assessment process, interim payment arrangements, and how to request a review of a dispute. Keep medical records and receipts.

Can I withdraw if I cannot afford continued travel?

Yes. Participation is voluntary. Tell the research team your decision and ask the doctor to discuss safely stopping treatment, adverse events that have already occurred, and options for further follow-up. Separately confirm how costs already incurred and compensation will be handled. Ethical Review Measures

Can my doctor back home carry out study follow-up?

Ask the study site to confirm whether the protocol allows this, the required test methods and time windows, and the requirements for sending results. Then ask your local doctor to confirm whether they can carry it out. Who handles costs and abnormal results should also be documented.

Sources

Checked on November 6, 2026. The rules below have different scopes of application. The specific study and any disputed classifications require further verification.

Chat on WhatsAppEmail